Spironolactone
Product Images NDC 53002-4722

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53002-4722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure1)

A Kaplan-Meier survival curve comparing the probability of survival over months between Spironolactone and placebo groups. The solid line represents placebo, and the dashed line represents Spironolactone, showing higher survival probability with Spironolactone. The graph includes sample sizes (Spironolactone n=822, placebo n=841) and a significant log-rank p-value (<0.001).*

FDA Label Image

Figure 2 (Figure2)

A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone to placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine levels, creatinine clearance levels, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The chart visually compares the effectiveness of spironolactone versus placebo across these subgroups.*

FDA Label Image

Label Image (Lbl530022806)

Spironolactone 100 mg tablets packaging label by RPK Pharmaceuticals, Inc. This label is for a bottle containing 100 tablets. The label includes dosage instructions stating to take one tablet three times a day, with placeholders for patient and clinic information as well as prescription details. The label also contains barcodes, NDC and lot numbers, and expiration information.*

FDA Label Image

Label Image (Lbl530024722)

Spironolactone 25 mg tablets by RPK Pharmaceuticals, Inc. The packaging label indicates 30 tablets per bottle, with instructions for tablet intake two times a day. The label includes barcodes, dosage information, and placeholders for clinic name and patient information.*

FDA Label Image

20 (Spironolactone Tablets Usp 1)

Chemical structure diagram of the active ingredient spironolactone, showing its molecular framework with labeled functional groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.